Sanofi
An insider at 4 companies in coverage, as reported on Form 4. SEC CIK 1121404. Latest Form 4 filed Feb 18, 2016.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Latigo Biotherapeutics, Inc.LTGO | 10% owner | 4 | 2026-08-10 | 2026-08-10 |
| Regeneron Pharmaceuticals, Inc.REGN | 10% owner | 551 | 2010-10-13 | 2020-06-09 |
| Fulcrum Therapeutics, Inc.FULC | 10% owner | 3 | 2019-07-22 | 2019-07-22 |
| Alnylam Pharmaceuticals, Inc.ALNY | 10% owner | 6 | 2015-01-22 | 2017-05-31 |
Transactions: 564
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2016-02-16 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,145 | $387.4283 | $831.0k | Form 4 |
| 2016-02-01 | Alnylam Pharmaceuticals, Inc.10% owner | Purchase | 205,030 | $69.75 | $14.3m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,563 | $472.641 | $1.7m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,600 | $471.5617 | $1.7m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 7,204 | $470.6444 | $3.4m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 14,169 | $469.7058 | $6.7m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 5,082 | $468.4646 | $2.4m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 4,901 | $467.6617 | $2.3m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,608 | $466.2618 | $1.7m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 8,002 | $465.4998 | $3.7m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 4,148 | $464.411 | $1.9m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,759 | $463.1723 | $1.3m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 4,941 | $462.2263 | $2.3m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,563 | $461.4128 | $1.6m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,500 | $460.1156 | $1.2m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,100 | $457.9952 | $1.4m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,220 | $457.1844 | $1.5m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,164 | $455.6774 | $986.1k | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,407 | $454.5971 | $1.1m | Form 4 |
| 2016-01-12 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 5,007 | $453.8912 | $2.3m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,300 | $469.461 | $1.1m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 1,702 | $468.4879 | $797.4k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,200 | $467.3464 | $1.0m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 900 | $466.0381 | $419.4k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 1,190 | $464.5745 | $552.8k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 5,812 | $463.7103 | $2.7m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 5,411 | $462.6074 | $2.5m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 9,271 | $461.6131 | $4.3m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 12,798 | $460.7054 | $5.9m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 6,697 | $459.5495 | $3.1m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 9,730 | $458.5797 | $4.5m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,938 | $457.6022 | $1.3m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,480 | $456.5556 | $1.1m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,601 | $455.558 | $1.6m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 4,140 | $454.4757 | $1.9m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,842 | $453.4794 | $1.7m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 1,768 | $452.3727 | $799.8k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 1,451 | $451.3084 | $654.8k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 1,200 | $450.2306 | $540.3k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 1,107 | $449.1383 | $497.2k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 100 | $476.85 | $47.7k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 700 | $476.3543 | $333.4k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 1,000 | $474.265 | $474.3k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 1,000 | $473.3125 | $473.3k | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 2,650 | $472.3657 | $1.3m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,625 | $471.6367 | $1.7m | Form 4 |
| 2015-10-06 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 1,965 | $470.4102 | $924.4k | Form 4 |
| 2015-09-23 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 3,729 | $539.9825 | $2.0m | Form 4 |
| 2015-09-23 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 11,212 | $539.1918 | $6.0m | Form 4 |
| 2015-09-23 | Regeneron Pharmaceuticals, Inc.10% owner | Purchase | 15,274 | $538.3122 | $8.2m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 01:12 ET. Listed shows no prices and gives no investment advice.